Skip to main content
CNVVY logo

ConvaTec Group Plc (CNVVY) Stock Price & Analysis

ConvaTec Group Plc (CNVVY) — price $13.90 (-1.91%), as of the Nov 20, 2026 trading session; market cap $6.63B.

Educational signal · not a buy or sell recommendation · How to read this

$13.90 −$0.27 (-1.91%) Market Cap $6.63B

ConvaTec Group Plc · CNVVY · Healthcare · Medical - Instruments & Supplies

Research dated 2026-09-13: ConvaTec develops and distributes medical devices for wound care, ostomy management, continence solutions, and hospital critical care across more than a hundred countries. The company's financial case turns on whether persistent debt can be serviced while the business matures into steady profitability.

Price as of Nov 20, 2026

Key Statistics

No MoonshotScore yet: we have not published a score for this company.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • TFX · Teleflex Incorporated · 61 /100
  • BLCO · Bausch + Lomb Corporation · 35 /100
  • HAE · Haemonetics Corporation · 83 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$13.90
Change on the day-1.91%
52-week range$10.45–$14.09
Market capitalisation$6.63B—
Price / earnings (trailing)51.37
Shares traded on the day4.0K
Beta (volatility vs the S&P 500)0.84

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 20, 2026: low $11, high $14, latest $14. $14 $11 high $14 Oct 17, 2025 Nov 20, 2026 · $14 $13Oct 17, 2025$13Oct 31, 2025$13Nov 14, 2025$13Nov 28, 2025$12Dec 12, 2025$13Dec 26, 2025$13Jan 9, 2026$13Jan 23, 2026$12Feb 6, 2026$12Feb 20, 2026$13Mar 6, 2026$12Mar 20, 2026$12Apr 2, 2026$13Apr 17, 2026$12May 1, 2026$11May 15, 2026$11May 29, 2026$11Jun 12, 2026$11Jun 26, 2026$11Jul 10, 2026$12Jul 24, 2026$13Aug 7, 2026$13Aug 21, 2026$13Sep 4, 2026$12Sep 18, 2026$11Oct 2, 2026$13Oct 16, 2026$13Oct 30, 2026$14Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for ConvaTec Group (CNVVY): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

3 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 20, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Debt/Equity Negative
ROE Neutral
Gross Margin Moderate

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is ConvaTec Group (CNVVY), and what does it report?

Short answer · as of

ConvaTec manufactures and distributes medical devices across four main categories: advanced wound-care products for acute and chronic wounds; ostomy care systems for patients with colostomies or ileostomies; continence solutions including intermittent catheters; and critical-care supplies for intensive-care units.

Customers include hospitals, healthcare providers, and patients who purchase through direct channels, distributors, and wholesalers.

The reported financial statements measure manufacturing throughput, sales mix, and gross-margin realization. Operating results reflect the spread between product cost and selling price, after deducting research, commercial expenses, and administrative overhead.

2 · Latest results

What do the latest results show for ConvaTec Group (CNVVY)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $1.23B.

The most recent quarter showed revenue and earnings per share both declined from the prior-year period, though the decline in reported earnings was steeper than the top-line contraction. Gross profit held as a percentage of revenue, indicating the margin pressure came from higher operating expenses rather than manufacturing cost inflation.

Management cited certain product transitions and integration headwinds as temporary factors, with a clear statement that operating margin should reach acceptable levels in the full year.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$1.23B$54M$0.11 (diluted)
Q4 FY2025$1.25B$70M$0.14 (diluted)
Q2 FY2025$1.18B$105M$0.20 (diluted)
Q4 FY2024$1.18B$111M$0.22 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for ConvaTec Group (CNVVY)?

Short answer

Cash and short-term investments were $0.00 at the Dec 31, 2025 balance-sheet date. This figure does not establish a cash runway.

Operating cash generation has been robust, though it fluctuates seasonally with working capital movements. The balance sheet carries significant debt relative to annual revenue and market value, with cash holdings covering only a fraction of total obligations. The company has sufficient liquidity to meet near-term needs, but leverage remains elevated.

4 · What to check next?

What should you watch next at ConvaTec Group (CNVVY)?

Watch whether the second half achieves the indicated margin recovery. Watch working capital: the company expects a seasonal reversal of cash outflows in the latter months. Watch free-cash-flow conversion to confirm management's expectation of near-total conversion to equity holders. Watch currency effects—management noted meaningful headwinds that may reverse if the dollar weakens.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • No insider Form 4 transaction falls inside the window this page reads.
  • Fewer than two score snapshots exist, so no score trend is shown.

Checked against the records this page reads, on the dates shown above.

5 · Score methodology

How is ConvaTec Group scored?

ConvaTec's footprint spans specialty healthcare (wound care, ostomy) rather than broad hospital supply or home health. Compared to diversified medical-device distributors, it holds a narrower product portfolio but deeper expertise in its chosen segments. Geographic presence covers developed markets primarily, with growing presence in emerging markets but less penetration than some larger competitors.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Sonic Healthcare Limited (SKHHY) Named competitor$14.21 Nov 20, 2026$7.14B— Model unavailable
Raia Drogasil S.A. (RADLY) Named competitor$2.36 Nov 20, 2026$4.13B— Model unavailable
Getinge AB (publ) (GNGBY) Named competitor$26.89 Nov 20, 2026$7.32B— Model unavailable
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) Named competitor$6.87 Nov 20, 2026$5.09B— Model unavailable
Sysmex Corporation (SSMXY) Named competitor$13.34 Nov 20, 2026$8.03B— Model unavailable
Teleflex Incorporated (TFX) Same industry, near in market value$161.58 Nov 20, 2026$6.41B— 5-pillar · not comparable
Bausch + Lomb Corporation (BLCO) Same industry, near in market value$20.69 Nov 19, 2026$7.40B— 5-pillar · not comparable
Haemonetics Corporation (HAE) Same industry, near in market value$120.16 Nov 20, 2026$5.47B— 5-pillar · not comparable
Merit Medical Systems, Inc. (MMSI) Same industry, near in market value$84.34 Nov 20, 2026$5.05B— 5-pillar · not comparable
AptarGroup, Inc. (ATR) Same industry, near in market value$140.08 Nov 20, 2026$8.88B— 5-pillar · not comparable
Avantor, Inc. (AVTR) Same industry, near in market value$14.84 Nov 20, 2026$10.1B— 5-pillar · not comparable
ICU Medical, Inc. (ICUI) Same industry, near in market value$172.52 Nov 20, 2026$4.31B— 5-pillar · not comparable

The comparison model is unavailable. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held CNVVY in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported CNVVY in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about ConvaTec Group (CNVVY)?

Read these with our analysis →

CNVVY Healthcare Stock FAQ

The last question is answered from this page's own dated data, not from the research.

Why does ConvaTec maintain such high debt levels?

The debt likely reflects prior acquisition strategy or dividend payouts. At current operating cash flows, the debt is serviceable but constrains financial flexibility for additional shareholder distributions.

What happens if hospital budgets contract or insurance coverage for ostomy products tightens?

Both risks would reduce unit volumes and push the company toward lower-margin channels or forced price concessions. The revenue mix already depends heavily on hospital and pharmacy purchasing decisions.

Is dividend income reliable from this company?

Dividends have been paid consistently, but they remain modest relative to earnings. Continued debt service takes priority; further increases are unlikely until leverage improves.

Where is most of the company's revenue coming from geographically?

The brief does not detail geographic revenue splits, only that distribution spans multiple countries and regions. Hospital and healthcare-provider concentration suggests developed-market weighting.

What is the CNVVY stock price today?

The last price recorded for ConvaTec Group Plc (CNVVY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Claude (claude-haiku-4-5) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 17 from Financial Modeling Prep (FMP) and 1 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Legal name; Business description; Cash against market value
  • 1. What is ConvaTec Group (CNVVY), and what does it report?: Business description; Quarterly income statement (USD thousands); Annual revenue and net result (USD millions)
  • 2. What do the latest results show for ConvaTec Group (CNVVY)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for ConvaTec Group (CNVVY)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash against market value
  • 4. What should you watch next at ConvaTec Group (CNVVY)?: Management outlook — dated call excerpts; Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions)
  • 5. How is ConvaTec Group scored?: Business description; Annual revenue and net result (USD millions); Analyst revenue and earnings estimates (average)
  • FAQ: Why does ConvaTec maintain such high debt levels?: Cash against market value; Operating cash flow by quarter (USD millions); Cash decline over the reported window
  • FAQ: What happens if hospital budgets contract or insurance coverage for ostomy products tightens?: Business description; Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters
  • FAQ: Is dividend income reliable from this company?: Recent dividends paid; Cash against market value; Trailing twelve-month ratio set
  • FAQ: Where is most of the company's revenue coming from geographically?: Business description; Reported versus estimated, last 8 quarters; Annual revenue and net result (USD millions)
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.